Key facts
- This page summarizes Jesse Selnick's Form 4 filing for Sight Sciences, Inc. (SGHT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2023, 05:30.
Jesse Selnick - 01 Jan 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- SGHT
- Reported as of
- 01 Jan 2023
- Net transaction value
- -$35,788
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2023, 05:30:26 UTC
- Prior SEC filing
- 17 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeremy Hayden, Attorney-in-Fact for Jesse Selnick
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jesse Selnick filed Form 4 for Sight Sciences, Inc. (SGHT) on 05 Jan 2023.
Change
- Previous filing in this sequence was filed on 17 May 2022.
- Current net transaction value: -$35,788.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGHT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +28,100
- Change %
- +7.4%
- Price
- $0.000000
- Shares after
- 406,250
- Date
- 01 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
SGHT
transaction
Common Stock
Tax liability
- Transaction value
- $35,788
- Shares
- -2,891
- Change %
- -0.71%
- Price
- $12.38
- Shares after
- 403,359
- Date
- 04 Jan 2023
- Ownership
- Direct
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.
Footnote F2
Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.
Footnote F3
Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs.
Footnote F4
Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.